Realcan Pharmaceutical Group Co., Ltd.

SZSE:002589.SZ

3.35 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.

2023202220212020201920182017201620152014201320122011201020092008
Omzet 8,034.36812,311.27821,059.71927,203.88435,258.50933,918.53423,293.6215,618.6669,749.9587,785.9075,925.8424,622.2383,195.4482,213.3831,601.7311,147.11
Kosten van de omzet 7,207.33610,639.20317,220.74222,227.12228,439.37127,424.64818,997.99313,171.3888,680.3437,080.5235,416.684,245.3292,933.6852,029.631,464.0931,045.467
Brutowinst 827.0321,672.0753,838.9774,976.7626,819.1386,493.8864,295.6282,447.2781,069.615705.384509.162376.909261.763183.753137.638101.643
Brutowinstmarge 0.1030.1360.1820.1830.1930.1910.1840.1570.110.0910.0860.0820.0820.0830.0860.089
Onderzoek- en ontwikkelingskosten 14.61622.67811.5638.9146.97100000000000
Algemene en administratieve kosten 170.64304.69428.135534.316663.145705.004469.752209.408107.13241.28526.59724.54522.33217.07415.19411.596
Verkoop- en marketingkosten 431.997847.1491,742.7792,174.9072,649.1762,164.5181,505.229931.974408.616234.026136.89295.92363.42639.73628.99622.376
Verkoop-, algemene en administratieve kosten 602.6361,151.8392,170.9132,709.2233,312.3212,869.5211,974.9811,141.382515.748275.311163.489120.46785.75856.8144.1933.972
Overige kosten -286.202430.448621.505662.241904.925780.739415.30316.8719.5476.02-1.26132.985-1.02816.79712.03312.029
Bedrijfskosten 891.8081,604.9642,803.9813,380.3784,224.2173,650.262,390.2851,414.289648.994378.904236.227167.205116.01876.72558.80946.852
Bedrijfsresultaat -126.63567.1111,300.241,704.0722,537.5972,701.4611,810.272861.345308.941235.769195.306151.942113.55585.14162.88939.642
Bedrijfsresultaat ratio -0.0160.0050.0620.0630.0720.080.0780.0550.0320.030.0330.0330.0360.0380.0390.035
Totaal overige inkomsten en kosten netto -8.782-1,811.022-835.222-788.593-2,435.222-738.8270.102-154.92-102.165-84.721-79.433-61.863-33.309-23.852-18.739-16.32
Inkomen voor belasting -135.418-1,743.912465.018915.479102.3761,962.6341,810.375878.069318.456241.759193.502147.841112.43783.17660.0938.471
Inkomen voor belasting ratio -0.017-0.1420.0220.0340.0030.0580.0780.0560.0330.0310.0330.0320.0350.0380.0380.034
Belastingkosten -167.389-4.43983.005290.927537.356684.828441.919202.99575.32359.99849.2637.17228.41421.04415.289.293
Nettowinst 20.318-1,739.473382.013624.552-434.981,277.8061,368.456590.759235.939180.987143.555110.65184.05762.10944.75729.178
Nettowinstmarge 0.003-0.1410.0180.023-0.0120.0380.0590.0380.0240.0230.0240.0240.0260.0280.0280.025
WPA (Winst Per Aandeel) 0.014-1.180.260.42-0.290.860.910.440.190.180.160.130.110.0970.0770.06
Verwaterde WPA 0.014-1.180.260.42-0.290.860.910.440.190.180.160.130.110.0970.0770.06
EBITDA 448.587-542.8641,619.4571,993.4132,812.4192,935.8032,019.1151,151.826488.205359.048285.467215.269150.097105.25675.59950.549
EBITDA ratio 0.056-0.0440.0770.0730.080.0870.0870.0740.050.0460.0480.0470.0470.0480.0470.044